Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

7.569 -0.271 (-3.45%)
Streaming Delayed Price Updated: 11:24 AM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
News headline image
Ginkgo Bioworks: Buy, Sell, or Hold? ↗
This company has a long way to go before investors will see rewards. 
Via The Motley Fool
News headline image
Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today? ↗
Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering. 
Via InvestorPlace
News headline image
Is a Giant Short Squeeze in Ginkgo Bioworks (DNA) Stock? ↗
DNA stock is up 15% today for little reason, fueling speculation that Ginkgo Bioworks may be in the midst of a short squeeze. 
Via InvestorPlace
News headline image
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest ↗
 
Via Benzinga
News headline image
Is Ginkgo Bioworks Stock a Buy? ↗
There's a lot to like about this business, but it's still a risky bet. 
Via The Motley Fool
News headline image
Why Ginkgo Bioworks Stock Is Sinking Today ↗
There wasn't much to like in Ginkgo's Q4 update. 
Via The Motley Fool
News headline image
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Novo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks. ↗
The collaboration could help solve challenges for both businesses. 
Via The Motley Fool
News headline image
What's Going On With Ginkgo Bioworks Stock? ↗
Ginkgo Bioworks announced the expansion of its strategic partnership with Novo Nordisk A/S on Wednesday under a framework agreement that initially is contemplated to run over five years.Ginkgo said the... 
Via Benzinga
News headline image
Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗
These stocks, a bargain today, are players to hold on to for the long term. 
Via The Motley Fool
News headline image
Earnings Scheduled For February 29, 2024 ↗
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Earnings Outlook For Ginkgo Bioworks Holdings ↗
 
Via Benzinga
News headline image
Is Ginkgo Bioworks Stock a Buy Now? ↗
Ginkgo Bioworks says it is experiencing strong growth from its biopharma customers. 
Via The Motley Fool
News headline image
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation ↗
They might not be profitable yet, but they're swinging for the fences. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now? ↗
These stocks could rocket higher, but they also present significant risks. 
Via The Motley Fool
News headline image
Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of... 
Via Benzinga
Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms
Via AB Newswire
Topics Supply Chain
News headline image
3 Pharmaceutical Stocks to Buy Hand Over Fist in March ↗
There are some great companies at attractive prices in the lucrative pharmaceutical space. 
Via The Motley Fool
News headline image
Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks? ↗
It isn't ready for membership today, but it could have a path in the future. 
Via The Motley Fool
News headline image
S&P 500, Nasdaq 100 Hit Record Highs As Dollar, Treasury Yields Weaken, Chipmakers Shine, NYCB Sinks: What's Driving Markets Friday? ↗
March began on a high note on Wall Street, with tech stocks driving indices to record levels. Despite weak data and mixed Fed remarks, investors remain optimistic. Semiconductor industry continues to... 
Via Benzinga
Topics Economy Stocks
News headline image
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results. 
Via Benzinga
News headline image
Why Ginkgo Bioworks Stock Is Down After Earnings ↗
Ginkgo said the decrease in sales was primarily driven by the expected ramp down of K-12 testing in Ginkgo's Biosecurity segment and the impact of Cell Engineering downstream value share from equity... 
Via Benzinga
News headline image
Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday. 
Via Benzinga
Topics Stocks
News headline image
bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network
From bit.bio
Via Business Wire
News headline image
2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value ↗
These two businesses have viable paths to making investors richer -- possibly soon. 
Via The Motley Fool
News headline image
7 Stocks Cathie Wood Is Still Loading Up On in Q1 ↗
You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future. 
Via InvestorPlace
News headline image
2 Cathie Wood Stocks With Jaw-Dropping Growth Potential ↗
These two platform biotechs could revolutionize the field of biologically based products. 
Via The Motley Fool
News headline image
Cathie Wood Just Bought These 3 Biotech Stocks. Should You? ↗
They aren't all long shots, but they're all innovative. 
Via The Motley Fool
News headline image
Not Shy Of Buying The Dip, Cathie Wood's Ark Mops Up Over $11M Worth Of Shares In Tesla — Sells Nvidia Stock ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.